51282
Deoxyfuconojirimycin 盐酸盐
≥98.0% (TLC)
别名:
1,5-Dideoxy-1,5-imino-L-fucitol 盐酸盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C6H13NO3 · HCl
化学文摘社编号:
分子量:
183.63
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12352201
MDL number:
InChI key
SHSBWMUIVLOMIL-NQZVPSPJSA-N
SMILES string
Cl.C[C@@H]1NC[C@@H](O)[C@H](O)[C@@H]1O
InChI
1S/C6H13NO3.ClH/c1-3-5(9)6(10)4(8)2-7-3;/h3-10H,2H2,1H3;1H/t3-,4+,5+,6-;/m0./s1
assay
≥98.0% (TLC)
Biochem/physiol Actions
Deoxyfuconojirimycin is a specific and competitive inhibitor of human liver α-L-fucosidase.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Other Notes
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression.
Kun Yuan et al.
Pathology oncology research : POR, 14(2), 145-156 (2008-06-17)
Glycosylation drives critical processes important for mammalian cell-cell and cell-matrix interactions. Alpha-L-fucose (alpha-L-f) is a key monosaccharide component of oligosaccharides that has been found to be overexpressed during tumor progression. Modification of cell surface fucosylation, we hypothesized, alters tumor cell
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持